Stockscreener 앱 받기
10.11
0.20%
-0.02
시간 외 거래:
10.11
전일 마감가:
$10.13
열려 있는:
$10.15
하루 거래량:
1.02M
Relative Volume:
0.62
시가총액:
$386.95M
수익:
$127.70M
순이익/손실:
$-121.25M
주가수익비율:
-3.2095
EPS:
-3.15
순현금흐름:
$-120.32M
1주 성능:
+0.20%
1개월 성능:
-0.10%
6개월 성능:
+33.20%
1년 성능:
-32.49%
1일 변동 폭
$10.10
$10.15
1주일 범위
$10.08
$10.15
52주 변동 폭
$4.80
$18.13
아이테오스 Stock (ITOS) Company Profile
명칭
Iteos Therapeutics Inc
전화
857-204-4583
주소
321 ARSENAL STREET, WATERTOWN
ITOS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ITOS
Iteos Therapeutics Inc
|
10.11 | 446.57M | 127.70M | -121.25M | -120.32M | -3.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
아이테오스 Stock (ITOS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-28 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2025-05-28 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-05-14 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-05-14 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-05-13 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-08-13 | 개시 | Wells Fargo | Overweight |
| 2021-05-05 | 개시 | H.C. Wainwright | Buy |
| 2020-10-08 | 개시 | Robert W. Baird | Outperform |
| 2020-08-18 | 개시 | JP Morgan | Overweight |
| 2020-08-18 | 개시 | Piper Sandler | Overweight |
| 2020-08-18 | 개시 | SVB Leerink | Outperform |
| 2020-08-18 | 개시 | Wedbush | Outperform |
모두보기
아이테오스 주식(ITOS)의 최신 뉴스
GSK and iTeos Therapeutics’ Promising Phase 3 Lung Cancer Study: Market Implications - TipRanks
Iteos Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
iTeos Therapeutics Faces Challenges Amid Collaboration Termination - TipRanks
iTeos Therapeutics, Inc. SEC 10-Q Report - TradingView
iTeos Therapeutics (ITOS.US) Boxer Capital, LLC sold 350,000 common shares worth approximately US$5.6927 million - 富途牛牛
iTeos Therapeutics Inc. Approaches Support With Recovery in SightAlpha Driven Watchlist With Alerts Published - metal.it
What makes iTeos Therapeutics Inc. stock price move sharplyDiscover undervalued opportunities early - Jammu Links News
What is iTeos Therapeutics Inc. company’s growth strategyGrow your portfolio with growth-oriented stocks - Jammu Links News
Is iTeos Therapeutics Inc. a growth stock or a value stockDiscover undervalued stocks ready to soar - Jammu Links News
What is the dividend policy of iTeos Therapeutics Inc. stockAchieve consistent double-digit returns - Jammu Links News
What catalysts could drive iTeos Therapeutics Inc. stock higher in 2025Build capital through low-risk investments - Jammu Links News
Is iTeos Therapeutics Inc. stock overvalued or undervaluedAchieve breakthrough results with expert guidance - Jammu Links News
How volatile is iTeos Therapeutics Inc. stock compared to the marketCapitalize on emerging investment opportunities - Jammu Links News
Price momentum metrics for iTeos Therapeutics Inc. explainedDaily Technical Forecast for Quick Gains - Newser
What are the technical indicators suggesting about iTeos Therapeutics Inc.Wealth Building Planner With Proven Results - Jammu Links News
Halper Sadeh Investigates iTeos Therapeutics, Veritex Holdings Merger Deals. - AInvest
Why iTeos Therapeutics Inc. stock attracts strong analyst attentionTrade Timing Strategy With Technical Data Explained - metal.it
Investigations into OLO, VBTX, ITOS, and WNS Shareholder Rights - AInvest
Reddit Investors Lose Big, Now Have Opportunity to Lead Fraud Lawsuit - AInvest
iTeos Therapeutics acquisition by Concentra Biosciences raises fiduciary duty concerns. - AInvest
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Visual trend scoring systems applied to iTeos Therapeutics Inc.Alpha Driven Watchlist With Alerts Published - metal.it
iTeos Therapeutics Inc. Added to High Probability Setup ListTriple Return Setup With Risk Control Explained - metal.it
These 10 Stocks are Winning Big - Insider Monkey
Is iTeos Therapeutics Inc. stock poised for growthReliable Investment Entry Signals Confirmed by Charts - metal.it
Using data tools to time your iTeos Therapeutics Inc. exitFree Early Entry Picks Before News Breakout - Newser
Can momentum traders help lift iTeos Therapeutics Inc.Trade Setup Builder with Custom Alerts - Newser
Price momentum metrics for iTeos Therapeutics Inc. explained Long-Term Safety Investment Analysis Report - Newser
How strong is iTeos Therapeutics Inc. company’s balance sheetInvest smarter with expert trading signals - Jammu Links News
Published on: 2025-07-27 21:40:11 - Jammu Links News
How Efficient Is iTeos Therapeutics Inc. at Controlling Operating CostsFree Deep Market Trend Analysis - Newser
Key External Factors That Drive iTeos Therapeutics Inc. Stock Price MovementsDaily Breakout Picks - Newser
Will iTeos Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsCapital Growth Picks - Newser
How iTeos Therapeutics Inc. stock performs during market volatilityFree Stock Selection with 300% Return - Newser
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ITOS, CIO, SNV on Behalf of Shareholders - GlobeNewswire Inc.
Wedbush Research Analysts Cut Earnings Estimates for ITOS - Defense World
iTeos Therapeutics Inc. Stock Analysis and ForecastRecord-breaking capital gains - PrintWeekIndia
Will iTeos Therapeutics Inc. stock split in the near futureHigh-yield investments - jammulinksnews.com
What drives iTeos Therapeutics Inc. stock priceExceptional growth trajectory - PrintWeekIndia
아이테오스 (ITOS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):